Loading clinical trials...
Loading clinical trials...
The purpose of this study is to demonstrate that the Eeva System may be used to identify embryos on Day 2 that are most likely to form blastocysts.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Progyny, Inc.
NCT07216742 · Infertility (IVF Patients)
NCT07515118 · Infertility, Ovarian Stimulation, and more
NCT07542626 · Azoospermia or Severe Oligozoospermia, Infertility, and more
NCT07499804 · IVF, Infertility, Female
NCT06826365 · Infertility, Female, Recurrent Miscarriage, and more
HRC Fertility
Encino, California
Stanford University
Palo Alto, California
Pacific Fertility Center
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions